• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. DERMABOND PRINEO 22CM; SURGICAL SEALANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. DERMABOND PRINEO 22CM; SURGICAL SEALANT Back to Search Results
Catalog Number CLR222
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bruise/Contusion (1754); Purulent Discharge (1812); Inflammation (1932); Tissue Damage (2104); Not Applicable (3189)
Event Date 07/01/2019
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Additional information received: what is the physicians opinion of the contributing factors to the reaction? surgeon believes to be a reaction to the adhesive.Patient pre-existing medical conditions (ie.Allergies, history of reactions).Please note patient has had prior exposure to prineo without adverse reaction for total hip replacement with the same surgeon within the prior 5 years.Patient has no known allergies and is otherwise in good health.Attempts have been made to obtain the following additional information, however not received to date: it was noted that antibiotics were prescribed and readmitted for wound management, was the reaction treated in any other manner (product removed; reoperation; reclosure; other prescription)? if so, please clarify.Please indicate any medical or surgical interventions performed.Please describe how was the adhesive was applied on the tape.What prep was used prior to, during or after prineo use? was a dressing placed over the incision? if so, what type of cover dressing used? what is the most current patient status? evaluation: the analysis results found that 11 clr222 devices were returned inside its package unopened.As per evaluation results, it was observed that the returned devices were received unopened and no issues were detected.Device unit was observed to be conforming to product specification.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.No conclusion could be reached as to what may have caused the reported incident.To date additional information requested has not been received.If further details are received at a later date a supplemental medwatch will be sent.
 
Event Description
It was reported a patient underwent a total knee replacement on (b)(6) 2019 and topical skin adhesive was used.On (b)(6) 2019, post operatively the patient re-presented at day 4 with marked skin reaction at the surgical site.Patient had inflammation, blisters, bruising and wound discharge.Patient was re-admitted to hospital.Treated with antibiotics and wound management.Additional information has been requested.
 
Manufacturer Narrative
Product complaint #: (b)(4).The following information was requested and the following was obtained: what prep was used prior to, during or after prineo use? betadine (povidone-iodine), or chlorhexidine? chlorhexidine.Was a protective, dry wound dressing such as gauze applied and was it applied only after the liquid topical skin adhesive has completely polymerized and the dermabond¿ prineo¿ is no longer tacky to the touch? no.Was the application site cleansed thoroughly with saline or isopropyl alcohol to remove any remaining blood, fluids, or topical medications/anaesthetics, including skin preps, and then patted dry? yes.Were any patch or sensitivity tests performed prior to the procedure? no.What is the most current patient status? reaction resolved and good cosmetic result.Were any iv steroid/topical steroid/oral steroid/other treatments used to manage the reaction? antibiotics & topical steroid.Who applies the product? the surgeon himself? surgeon only with consistent ifu compliant technique.If the reaction is on the knee, was the product applied while knee was extended or flexed? fully flexed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DERMABOND PRINEO 22CM
Type of Device
SURGICAL SEALANT
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
MDR Report Key8845772
MDR Text Key152781320
Report Number2210968-2019-84918
Device Sequence Number1
Product Code OMD
UDI-Device Identifier10705031237339
UDI-Public10705031237339
Combination Product (y/n)N
PMA/PMN Number
K133864
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 07/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/31/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2020
Device Catalogue NumberCLR222
Device Lot NumberMKJ678
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/30/2019
Date Manufacturer Received08/26/2019
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age61 YR
Patient Weight74
-
-